A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

Both published and newer data suggests that DNase I impedes neutrophil tumor infiltration, promotes CD4 and CD8 T cell infiltration, and enhances intratumoral T cell activation. DNase I plus -CTLA-4 ...

In the urology space, initial clinical trials of ANKTIVA are being designed for high-risk prostate cancer," said Dr. Patrick ...

Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Encouraging Preclinical Data: Decoy20 has produced efficacy in preclinical studies across a variety of tumor types and in combination with four different classes of existing drugs, demonstrating both ...

22% of CD8+ T-cells are located in stroma areas (outlined in green). Distance of tumor cells from blood vessels ... with DAPI and for FOXP3, CD25 and CD4.

Michelle Monje-Deisseroth says she first treated patients with “the worst imaginable childhood brain tumor” as a medical ... Most children didn’t survive a year. Monje-Deisseroth dedicated ...

Summary: Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in adults. This approach not only attacks tumor cells directly but ...

Figure 1: Pathological findings and flow cytometric analysis of lymphoma cells in Tax transgenic mice.